greeksoup/ stock research
Stock research / United States / SNY / Year to 31 December 2016

Sanofi (SNY) annual results, year to 31 December 2016: revenue EUR 33,809 million, from the 20-F

Sanofi files a 20-F with the SEC once a year, in euros. In the year to 31 December 2016 it reported revenue from the sale of goods of EUR 33,809 million ($37.4 billion at the year's average rate), down 0.7% on the year before. Its profit attributable to shareholders was EUR 4,709 million, up 9.8%, and diluted earnings per share EUR 3.63.

Revenue
EUR 33,809 million
-0.7% on the year
FY2015FY2016
Operating margin
19.3%
16.5% a year earlier
FY2015FY2016
Net income
EUR 4,709 million
+9.8% on the year
FY2015FY2016
Diluted EPS
EUR 3.63
+11.7% on the year
FY2015FY2016

this yearthe year beforeIn euros as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toDec 2015Dec 2016
Revenue from the sale of goods34,06033,809
Cost of sales10,91910,701
Gross profit23,94223,995
Research and development5,0825,172
Selling, general and administrative9,3829,478
Operating profit5,6246,531
Finance costs559924
Income tax7091,325
Profit for the year4,3884,800
Profit attributable to shareholders4,2874,709
Filing20-F20-F
EUR million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toDec 2015Dec 2016
Diluted EPS3.253.63
Basic EPS3.283.66
Filing20-F20-F

EUR per ordinary share, as filed.

Cash flow

Year toDec 2015Dec 2016
Cash from operations8,2907,838
Cash from investing-3,011-2,511
Cash from financing-3,578-4,101
Buybacks1,7842,908
Dividends paid3,6943,759
Filing20-F20-F

EUR million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toDec 2015Dec 2016
Funded by
Equity attributable to shareholders58,04957,552
Non-controlling interests161170
Borrowings, as filed16,39818,509
Other liabilities27,71328,448
Total equity and liabilities102,321104,679
Owned
Property, plant and equipment9,94310,019
Goodwill39,55740,287
Other intangible assets12,02610,879
Cash and cash equivalents9,14810,273
Inventories6,5166,896
Other assets25,13126,325
Total assets102,321104,679
Filing20-F20-F

EUR million, at each fiscal year end.

Ratios on the filed lines

Year toDec 2015Dec 2016
Return on year-end equity7.4%8.2%
Filing20-F20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 December 2016, filed 8 March 2019: the filing. The figures are in euros as filed.